Forskningsradar
← Economics
Economics 4.9

How companies measure patient well-being is about to get serious scrutiny

A new scoping review examines how the visual analogue scale—a simple tool where patients rate their health on a line from 0 to 100—is being used in clinical research and real-world healthcare decisions. The finding matters because these measurements increasingly drive pharmaceutical approvals, insurance coverage decisions, and treatment pricing across major markets.

Originaltitel: Use of the visual analogue scale for health state valuation: a scoping review

Generera ett redaktionellt utkast på svenska